During the past decade, Universitatspital Zurich - Klinik fur Neurologie & Hirntumorzentrum conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitatspital Zurich - Klinik fur Neurologie & Hirntumorzentrum" are "Glioblastoma" (1 trials) and "Glioma of Brain" (1 trials). Many other conditions were trialed in "Universitatspital Zurich - Klinik fur Neurologie & Hirntumorzentrum" in a lesser frequency.

Most popular intervention types in "Universitatspital Zurich - Klinik fur Neurologie & Hirntumorzentrum" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "L19TNF" (2 trials) and "Lomustine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitatspital Zurich - Klinik fur Neurologie & Hirntumorzentrum" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitatspital Zurich - Klinik fur Neurologie & Hirntumorzentrum". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Universitatspital Zurich - Klinik fur Neurologie & Hirntumorzentrum, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitatspital Zurich - Klinik fur Neurologie & Hirntumorzentrum, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".